286 related articles for article (PubMed ID: 19027789)
21. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
22. Sphingolipids and cell death.
Morales A; Lee H; Goñi FM; Kolesnick R; Fernandez-Checa JC
Apoptosis; 2007 May; 12(5):923-39. PubMed ID: 17294080
[TBL] [Abstract][Full Text] [Related]
23. Sphingolipids in infectious diseases.
Hanada K
Jpn J Infect Dis; 2005 Jun; 58(3):131-48. PubMed ID: 15973004
[TBL] [Abstract][Full Text] [Related]
24. Ceramidases, roles in sphingolipid metabolism and in health and disease.
Coant N; Sakamoto W; Mao C; Hannun YA
Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
[TBL] [Abstract][Full Text] [Related]
25. Sphingolipids and response to chemotherapy.
Dimanche-Boitrel MT; Rebillard A
Handb Exp Pharmacol; 2013; (216):73-91. PubMed ID: 23563652
[TBL] [Abstract][Full Text] [Related]
26. Ceramide signaling in the gut.
Li Y; Nicholson RJ; Summers SA
Mol Cell Endocrinol; 2022 Mar; 544():111554. PubMed ID: 34998898
[TBL] [Abstract][Full Text] [Related]
27. Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry.
Sullards MC; Wang E; Peng Q; Merrill AH
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):789-97. PubMed ID: 14528916
[TBL] [Abstract][Full Text] [Related]
28. Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation.
Li YC; Chen Y; Du J
J Steroid Biochem Mol Biol; 2015 Apr; 148():179-83. PubMed ID: 25603468
[TBL] [Abstract][Full Text] [Related]
29. [Sphingolipid and apoptosis].
Wang J; Hu XS; Shi JP
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):217-21. PubMed ID: 14628466
[TBL] [Abstract][Full Text] [Related]
30. Sphingolipids in cancer.
Furuya H; Shimizu Y; Kawamori T
Cancer Metastasis Rev; 2011 Dec; 30(3-4):567-76. PubMed ID: 22005951
[TBL] [Abstract][Full Text] [Related]
31. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
[TBL] [Abstract][Full Text] [Related]
32. Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
Nixon GF
Br J Pharmacol; 2009 Oct; 158(4):982-93. PubMed ID: 19563535
[TBL] [Abstract][Full Text] [Related]
33. Sphingolipid signaling and redox regulation.
Won JS; Singh I
Free Radic Biol Med; 2006 Jun; 40(11):1875-88. PubMed ID: 16716889
[TBL] [Abstract][Full Text] [Related]
34. Sphingolipids in colon cancer.
García-Barros M; Coant N; Truman JP; Snider AJ; Hannun YA
Biochim Biophys Acta; 2014 May; 1841(5):773-82. PubMed ID: 24060581
[TBL] [Abstract][Full Text] [Related]
35. Translational aspects of sphingolipid metabolism.
Zeidan YH; Hannun YA
Trends Mol Med; 2007 Aug; 13(8):327-36. PubMed ID: 17588815
[TBL] [Abstract][Full Text] [Related]
36. Role of Sphingolipids in Infant Gut Health and Immunity.
Nilsson Å
J Pediatr; 2016 Jun; 173 Suppl():S53-9. PubMed ID: 27234412
[TBL] [Abstract][Full Text] [Related]
37. Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.
Norris GH; Blesso CN
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29143791
[TBL] [Abstract][Full Text] [Related]
38. Sphingosine kinase-1--a potential therapeutic target in cancer.
Cuvillier O
Anticancer Drugs; 2007 Feb; 18(2):105-10. PubMed ID: 17159597
[TBL] [Abstract][Full Text] [Related]
39. Sphingolipid metabolites in neural signalling and function.
Colombaioni L; Garcia-Gil M
Brain Res Brain Res Rev; 2004 Nov; 46(3):328-55. PubMed ID: 15571774
[TBL] [Abstract][Full Text] [Related]
40. Chemical tools to investigate sphingolipid metabolism and functions.
Delgado A; Casas J; Llebaria A; Abad JL; Fabriás G
ChemMedChem; 2007 May; 2(5):580-606. PubMed ID: 17252619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
